SPC
MRTX

Sigma Planning Corp’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Sigma Planning Corp’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,950
Closed -$201K – 1063
2019
Q2 		$201K Buy
+1,950
New +$201K 0.01% 903